Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 16
Gene Symbol: AARS1
AARS1
0.100 Biomarker disease HPO
Entrez Id: 24
Gene Symbol: ABCA4
ABCA4
0.010 Biomarker disease BEFREE The results suggest that the personality trait Openness, but not any other FFM factor, is linked to neurocognitive profiles in ADHD. 28844557 2017
Entrez Id: 56476
Gene Symbol: ABCB10P1
ABCB10P1
0.030 Biomarker disease BEFREE The SCAN-3:C and SCAN-3:A test batteries were used to assess auditory processing abilities; Lucid Ability test for NVIQ; Children's Communication Checklist-2 (CCC-2) for language ability; Swanson Nolan and Pelham-IV Rating Scale (SNAP-IV) for ADHD; and the manual dexterity components of the Movement Assessment Battery for Children-2 (MABC-2) as a screening tool for DCD. 30262367 2018
Entrez Id: 56476
Gene Symbol: ABCB10P1
ABCB10P1
0.030 AlteredExpression disease BEFREE Rhythmicity of finger tapping (P = 0.008) and performance on the dexterity (P = 0.007) and aiming and catching (P = 0.042) components of the MABC-2 were also significantly poorer in the ADHD group than controls. 29234901 2018
Entrez Id: 56476
Gene Symbol: ABCB10P1
ABCB10P1
0.030 GeneticVariation disease BEFREE Once other variables such as age, gender, SES, and ADHD symptomatology were taken into account, the only BRIEF-P subscale that was associated with the MABC-2 Total Score was the Working Memory subscale. 28153568 2017
Entrez Id: 215
Gene Symbol: ABCD1
ABCD1
0.100 Biomarker disease HPO
Entrez Id: 31
Gene Symbol: ACACA
ACACA
0.010 Biomarker disease BEFREE In sum, ADHD and OCD patients showed mostly disorder-specific patterns of brain abnormalities in both task positive salience/ventral attention networks with lateral frontal deficits in ADHD and middle ACC deficits in OCD, as well as in their deactivation patterns in medial frontal DMN regions. 28529874 2017
Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3
0.040 Biomarker disease BEFREE Here we report a previously unidentified association between G protein-coupled receptor kinase-interacting protein-1 (GIT1) and ADHD in humans. 21499268 2011
Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3
0.040 Biomarker disease BEFREE G protein-coupled receptor kinase-interacting protein-1 (GIT1) has recently been reported to be associated with ADHD in human and the genetic deletion of GIT1 result in ADHD-like behaviors in mice. 28912643 2017
Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3
0.040 Biomarker disease BEFREE Recently, a Korean group assessed the G-protein-coupled receptor kinase-interacting protein 1 (GIT1) gene that had previously been associated with ADHD. 22897819 2012
Entrez Id: 57007
Gene Symbol: ACKR3
ACKR3
0.040 GeneticVariation disease BEFREE The G protein-coupled receptor kinase interacting protein 1 gene (<i>GIT1</i>) has been proposed to be a risk gene for attention deficit hyperactivity disorder (ADHD), and it regulates the endocytosis of G protein-coupled receptors like dopamine receptors. 28948080 2017
Entrez Id: 55289
Gene Symbol: ACOXL
ACOXL
0.100 GeneticVariation disease GWASCAT New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder. 26174813 2015
Entrez Id: 2182
Gene Symbol: ACSL4
ACSL4
0.100 Biomarker disease HPO
Entrez Id: 51412
Gene Symbol: ACTL6B
ACTL6B
0.100 Biomarker disease HPO
Entrez Id: 8038
Gene Symbol: ADAM12
ADAM12
0.100 GeneticVariation disease GWASCAT Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder. 27021288 2016
Entrez Id: 8038
Gene Symbol: ADAM12
ADAM12
0.100 GeneticVariation disease GWASCAT Gene-set and multivariate genome-wide association analysis of oppositional defiant behavior subtypes in attention-deficit/hyperactivity disorder. 26184070 2016
Entrez Id: 9509
Gene Symbol: ADAMTS2
ADAMTS2
0.010 Biomarker disease BEFREE However, relatives of anxious probands and NPI controls did not differ for ADHD. 8755795 1996
Entrez Id: 108
Gene Symbol: ADCY2
ADCY2
0.100 GeneticVariation disease GWASCAT Genetic Overlap Between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence From Genome-wide Association Study Meta-analysis. 27890468 2017
Entrez Id: 23284
Gene Symbol: ADGRL3
ADGRL3
0.400 GeneticVariation disease BEFREE In the present study, we examined the association between the LPHN3 rs6551665 A/G polymorphism and ADHD in Korea. 25871512 2015
Entrez Id: 23284
Gene Symbol: ADGRL3
ADGRL3
0.400 GeneticVariation disease BEFREE We found that SNPs within the LPHN3 gene interact with SNPs spanning the 11q region that contains DRD2 and NCAM1 not only to increase the risk of developing ADHD but also to increase ADHD severity. 22832519 2011
Entrez Id: 23284
Gene Symbol: ADGRL3
ADGRL3
0.400 GeneticVariation disease BEFREE As we have identified that common variants of the LPHN3 gene were responsible for the 4q linkage signal, we focused on 4q-11q interaction to determine that single-nucleotide polymorphisms (SNPs) harbored in the LPHN3 gene interact with SNPs spanning the 11q region that contains DRD2 and NCAM1 genes, to double the risk of developing ADHD. 21606926 2012
Entrez Id: 23284
Gene Symbol: ADGRL3
ADGRL3
0.400 GeneticVariation disease BEFREE Interestingly, the 4q13.1 linkage peak (lod 2.34) occurred immediately upstream of the LPHN3 gene, recently reported both linked and associated with ADHD. 23190410 2013
Entrez Id: 23284
Gene Symbol: ADGRL3
ADGRL3
0.400 GeneticVariation disease BEFREE The results of our study further strengthen the concept of an LPHN3 risk haplotype for ADHD and support the usefulness of the endophenotype approach in psychiatric and psychological research. 23245769 2013
Entrez Id: 23284
Gene Symbol: ADGRL3
ADGRL3
0.400 Biomarker disease BEFREE Linkage and replicated association of ADHD with a novel non-candidate gene (LPHN3) provide new insights into the genetics, neurobiology, and treatment of ADHD. 20157310 2010
Entrez Id: 23284
Gene Symbol: ADGRL3
ADGRL3
0.400 Biomarker disease BEFREE The substantial heritability of ADHD is well documented and recent genome-wide analyses for risk genes revealed synaptic adhesion molecules (e.g. latrophilin-3, LPHN3; fibronectin leucine-rich repeat transmembrane protein-3, FLRT3), glutamate receptors (e.g. metabotropic glutamate receptor-5, GRM5) and mediators of intracellular signalling pathways (e.g. nitric oxide synthase-1, NOS1). 22939004 2013